文献速递免疫规划

B群脑膜炎奈瑟菌外膜囊泡不同免疫途径及两种佐剂比较研究

Study of different routes of immunization using outer membrane vesicles of Neisseria meningitidis B and comparison of two adjuvants.
PubMed 文献 · Vaccine · 2020-10-17

研究以B群脑膜炎奈瑟菌外膜囊泡(OMV)为抗原,分别联合DDA-BF或氢氧化铝(AH)佐剂,经不同途径免疫瑞士小鼠,比较体液与细胞免疫应答。总体定量分析中AH优于DDA-BF,但IgG亲和力指数、杀菌活性和免疫印迹等分析未显示佐剂或免疫途径间重要差异,无法判定优劣。

要点

  • OMV抗原可诱导小鼠产生体液和细胞免疫应答。
  • 总体定量分析中氢氧化铝佐剂优于DDA-BF佐剂。
  • IgG亲和力、杀菌活性等指标未显示佐剂或途径间重要差异。

核心结论

  • 就所测参数而言,无法判定所研究的佐剂和免疫途径之间存在优劣。

研究设计与样本

  • 用B群脑膜炎奈瑟菌外膜囊泡(OMV)联合DDA-BF或氢氧化铝(AH)佐剂,经不同途径免疫瑞士小鼠。
  • 通过ELISA、免疫印迹、迟发型超敏反应(DTH)和組織病理学分析比较免疫应答。

主要发现

  • 抗原制备物可诱导小鼠产生体液和细胞免疫应答。
  • 总体定量分析中氢氧化铝(AH)优于DDA-BF。
  • IgG亲和力指数、杀菌活性和免疫印迹分析未显示佐剂或免疫途径间重要差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Outer membrane vesicles (OMVs) of Neisseria meningitidis contain important antigens to trigger an immune response against meningococci and have been studied as vaccines compounds. The immune response to a vaccine may be affected by its constitution and route of administration. Therefore, Swiss mice were immunized by different routes with OMVs of N. meningitidis B with dimethyl dioctadecyl ammonium bromide in bilayer fragments (DDA-BF) or aluminum hydroxide (AH) as adjuvants. The adjuvants and different routes were compared regarding the immune responses by ELISA, western blot, delayed type hypersensitivity (DTH) and histopathologic analysis. The antigenic preparation generated humoral and cellular immune responses. In quantitative analyzes, in general, AH was superior to DDA-BF. However, analysis such as IgG avidity index, bactericidal activity and immunoblot, revealed no important differences regarding the adjuvant or route of immunization. Regarding the parameters tested, it was not possible to define a superiority between the adjuvants and routes of immunization proposed by this study.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Brito LT, Rinaldi FM, Gaspar EB, et al. Study of different routes of immunization using outer membrane vesicles of Neisseria meningitidis B and comparison of two adjuvants. Vaccine. 2020. PMID: 33082014. doi:10.1016/j.vaccine.2020.09.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。